Sarcomatoid carcinoma of the lung, Cancer, vol.60, issue.4, pp.608-616, 1999. ,
DOI : 10.1002/(SICI)1097-0142(19990815)86:4<608::AID-CNCR9>3.0.CO;2-1
Pathology of lung cancer, Clinics in Chest Medicine, vol.23, issue.1, pp.65-81, 2002. ,
DOI : 10.1016/S0272-5231(03)00061-3
Pulmonary Carcinomas With Pleomorphic, Sarcomatoid, or Sarcomatous Elements, The American Journal of Surgical Pathology, vol.27, issue.3, pp.311-324, 2003. ,
DOI : 10.1097/00000478-200303000-00004
Review Article: Pulmonary Sarcomatoid Carcinomas: A Practical Overview, International Journal of Surgical Pathology, vol.18, issue.2, pp.103-120, 2010. ,
DOI : 10.1177/1066896908330049
Giant Cell Carcinoma of the Lung, Chest, vol.89, issue.3, pp.366-369, 1986. ,
DOI : 10.1378/chest.89.3.366
Giant cell carcinoma of the lung. Cancer 1992 août, pp.606-610 ,
Personal Experience in Surgical Management of Pulmonary Pleomorphic Carcinoma, The Annals of Thoracic Surgery, vol.78, issue.5, pp.1742-1747, 2004. ,
DOI : 10.1016/j.athoracsur.2004.04.084
Pleomorphic Carcinoma of the Lung, The American Journal of Surgical Pathology, vol.32, issue.11, pp.1727-1735, 2008. ,
DOI : 10.1097/PAS.0b013e3181804302
Pulmonary carcinomas with a sarcomatoid element: An immunocytochemical and ultrastructural analysis, Human Pathology, vol.19, issue.2, pp.155-165, 1988. ,
DOI : 10.1016/S0046-8177(88)80343-5
Carcinosarcoma and spindle cell carcinoma of the lung. Clinicopathologic and immunohistochemical studies, J. Thorac. Cardiovasc. Surg, vol.100, issue.6, pp.844-852, 1990. ,
Histochemical and ultrastructural features of an unusual pulmonary carcinosarcoma, Human Pathology, vol.12, issue.11, pp.1046-1051, 1981. ,
DOI : 10.1016/S0046-8177(81)80267-5
Carcinosarcoma of the Lung: Mayo Clinic Experience and Response to Chemotherapy, Mayo Clinic Proceedings, vol.59, issue.9, pp.598-603, 1984. ,
DOI : 10.1016/S0025-6196(12)62410-0
Carcinosarcomas of the Lung, The American Journal of Surgical Pathology, vol.23, issue.12, pp.1514-1526, 1999. ,
DOI : 10.1097/00000478-199912000-00009
A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis, European Respiratory Journal, vol.36, issue.5, pp.1067-1072, 2010. ,
DOI : 10.1183/09031936.00152609
Carcinosarcoma of lung associated with asbestosis, Histopathology, vol.59, issue.5, pp.484-486, 1995. ,
DOI : 10.1111/j.1749-6632.1979.tb18749.x
Pulmonary blastoma: cytopathologic and histopathologic findings, Acta Cytol, vol.20, issue.4, pp.381-386, 1976. ,
Pulmonary Sarcomatoid Carcinomas: A Practical Overview [Internet], International Journal of Surgical Pathology, 2009. ,
Giant cell adenocarcinoma of the lung. Cancer 1966 oct, pp.1337-1346 ,
Sarcomatoid neoplasms of the lung and pleura, Arch. Pathol. Lab. Med, vol.134, issue.11, pp.1645-1658, 2010. ,
Pulmonary carcinosarcoma: A case study and review of the literature, British Journal of Diseases of the Chest, vol.79, issue.1, pp.83-94, 1985. ,
DOI : 10.1016/0007-0971(85)90011-7
Sarcomatoid carcinoma of the lung. Immunohistochemieal and ultrastructural studies of 14 cases, Cancer, vol.87, issue.2, pp.376-386, 1992. ,
DOI : 10.1002/1097-0142(19920115)69:2<376::AID-CNCR2820690218>3.0.CO;2-U
Pulmonary pleomorphic (spindle) cell carcinoma: peculiar clinicopathologic manifestations different from ordinary non-small cell carcinoma, Lung Cancer, vol.34, issue.1, pp.91-97, 2001. ,
DOI : 10.1016/S0169-5002(01)00224-0
Expression of caveolin-1 in pleomorphic carcinoma of the lung is correlated with a poor prognosis, Anticancer Res, vol.25, issue.6C, pp.4631-4637, 2005. ,
Pulmonary blastoma: report of five cases and identification of clinical features suggestive of the disease, European Journal of Cardio-Thoracic Surgery, vol.22, issue.5, pp.708-711, 2002. ,
DOI : 10.1016/S1010-7940(02)00529-8
Pulmonary Giant Cell Carcinoma, The Annals of Thoracic Surgery, vol.21, issue.6, pp.540-545, 1976. ,
DOI : 10.1016/S0003-4975(10)63926-4
Pleomorphic Carcinomas of the Lung Show a Selective Distribution of Gene Products Involved in Cell Differentiation, Cell Cycle Control, Tumor Growth, and Tumor Cell Motility, The American Journal of Surgical Pathology, vol.27, issue.9, pp.1203-1215, 2003. ,
DOI : 10.1097/00000478-200309000-00003
p53 and K-ras Mutational Genotyping in Pulmonary Carcinosarcoma, Spindle Cell Carcinoma, and Pulmonary Blastoma: Implications for Histogenesis, The American Journal of Surgical Pathology, vol.21, issue.7, pp.801-811, 1997. ,
DOI : 10.1097/00000478-199707000-00008
Sarcomatoid carcinomas of the lung--are these histogenetically heterogeneous tumors? Virchows Arch, pp.455-461, 2006. ,
Pulmonary Pleomorphic Carcinoma: A Clinicopathological Study Including EGFR Mutation Analysis, Journal of Thoracic Oncology, vol.5, issue.4, pp.460-465, 2010. ,
DOI : 10.1097/JTO.0b013e3181ce3e3c
Lymphoproliferative Diseases,and Other Primary Malignant Tumors. Dans: Murray and Nadel's textbook of respiratory medicine, 2009. ,
Lung carcinoma with spindle cell components: Sixteen cases examined by immunohistochemistry, Human Pathology, vol.23, issue.11, pp.1289-1297, 1992. ,
DOI : 10.1016/0046-8177(92)90298-H
The expression of trophoblastic cell markers by lung carcinomas, Human Pathology, vol.26, issue.11, pp.1201-1206, 1995. ,
DOI : 10.1016/0046-8177(95)90194-9
Biphasic malignant mesothelioma cases with osseous differentiation and long survival: A review of the literature, Lung Cancer, vol.57, issue.2, pp.233-236, 2007. ,
DOI : 10.1016/j.lungcan.2007.01.033
Carcinosarcoma of the Colon: Report of a Rare Tumor, Pathology - Research and Practice, vol.199, issue.5, pp.345-348, 2003. ,
DOI : 10.1078/0344-0338-0428
Primary heterologous carcinosarcoma (Metaplastic carcinoma) of the urinary bladder, Cancer, vol.10, issue.8, pp.1535-1549, 1998. ,
DOI : 10.1002/(SICI)1097-0142(19980415)82:8<1535::AID-CNCR16>3.0.CO;2-5
Gastric carcinosarcoma (sarcomatoid carcinoma) with rhabdomyoblastic and osteoblastic differentiation, Pathology International, vol.66, issue.8, pp.557-563, 1997. ,
DOI : 10.1111/j.1440-1827.1997.tb04540.x
Sarcomatoid lung cancer (spindle/giant cells): An aggressive disease?, The Journal of Thoracic and Cardiovascular Surgery, vol.134, issue.3, pp.619-623, 2007. ,
DOI : 10.1016/j.jtcvs.2007.05.031
Immunhistochemistry by Means of Widely Agreed-Upon Markers (Cytokeratins 5/6 and 7, p63, Thyroid Transcription Factor-1, and Vimentin) on Small Biopsies of Non-small Cell Lung Cancer Effectively Parallels the Corresponding Profiling and Eventual Diagnoses on Surgical Specimens, Journal of Thoracic Oncology, vol.6, issue.6, pp.1039-1049, 2011. ,
DOI : 10.1097/JTO.0b013e318211dd16
Inflammatory sarcomatoid carcinoma of the lung: Report of three cases and clinicopathologic comparison with inflammatory pseudotumors in adult patients, Human Pathology, vol.26, issue.9, pp.1014-1021, 1995. ,
DOI : 10.1016/0046-8177(95)90092-6
Synovial sarcoma of the pleura and its differentiation from other primary pleural tumours: a clinicopathological and immunohistochemical review of three cases, Histopathology, vol.72, issue.6, pp.508-513, 1998. ,
DOI : 10.1097/00000478-199612000-00001
The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain, Development, vol.113, issue.4, pp.1093-1104, 1991. ,
The lung-specific surfactant protein B gene promoter is a target for thyroid transcription factor 1 and hepatocyte nuclear factor 3, indicating common factors for organ-specific gene expression along the foregut axis., Molecular and Cellular Biology, vol.14, issue.9, pp.5671-5681, 1994. ,
DOI : 10.1128/MCB.14.9.5671
Is TTF1 a good immunohistochemical marker to distinguish primary from metastatic lung adenocarcinomas?, Pathology - Research and Practice, vol.196, issue.12, pp.835-840, 2000. ,
DOI : 10.1016/S0344-0338(00)80084-9
Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens, Modern Pathology, vol.6, issue.10, pp.1348-1359, 2011. ,
DOI : 10.1016/j.lungcan.2010.09.013
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma, Journal of Thoracic Oncology, vol.6, issue.2, pp.244-285, 2011. ,
DOI : 10.1097/JTO.0b013e318206a221
URL : https://hal.archives-ouvertes.fr/inserm-00561753
Alternative epithelial markers in sarcomatoid carcinomas of the head and neck, lung, and bladder???p63, MOC-31, and TTF-1, Modern Pathology, vol.17, issue.11, pp.1471-1481, 2005. ,
DOI : 10.1038/modpathol.3800451
Sarcomatoid mesothelioma and its histological mimics: a comparative immunohistochemical study, Histopathology, vol.26, issue.3, pp.270-279, 2003. ,
DOI : 10.1097/00000478-199712000-00016
Loss of p63 Expression Is Associated with Tumor Progression in Bladder Cancer, The American Journal of Pathology, vol.161, issue.4, pp.1199-1206, 2002. ,
DOI : 10.1016/S0002-9440(10)64396-9
p63 contributes to cell invasion and migration in squamous cell carcinoma of the head and neck. Cancer Lett, pp.26-34, 2008. ,
The Use of P63 Immunohistochemistry for the Identification of Squamous Cell Carcinoma of the Lung, PLoS ONE, vol.9, issue.8, p.12209, 2010. ,
DOI : 10.1371/journal.pone.0012209.t003
Refining the Diagnosis and EGFR Status of Non-small Cell Lung Carcinoma in Biopsy and Cytologic Material, Using a Panel of Mucin Staining, TTF-1, Cytokeratin 5/6, and P63, and EGFR Mutation Analysis, Journal of Thoracic Oncology, vol.5, issue.4, pp.436-441, 2010. ,
DOI : 10.1097/JTO.0b013e3181c6ed9b
Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group, Arch. Pathol. Lab. Med, vol.133, issue.8, pp.1317-1331, 2009. ,
The diagnostic utility of immunohistochemistry in distinguishing between epithelioid mesotheliomas and squamous carcinomas of the lung: a comparative study, Modern Pathology, vol.8, issue.3, pp.417-428, 2006. ,
DOI : 10.1046/j.1365-2559.2002.01328.x
Classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: strategies, applications, and limitations, Lab. Invest, vol.52, issue.3, pp.243-256, 1985. ,
Value of Cytokeratin 5/6 Immunostaining in Distinguishing Epithelial Mesothelioma of the Pleura From Lung Adenocarcinoma, The American Journal of Surgical Pathology, vol.22, issue.10, pp.1215-1221, 1998. ,
DOI : 10.1097/00000478-199810000-00006
Expression of E-cadherin and vimentin correlates with metastasis formation in head and neck squamous cell carcinoma patients, Radiotherapy and Oncology, vol.99, issue.3, pp.344-348, 2011. ,
DOI : 10.1016/j.radonc.2011.05.066
Value of immunohistochemistry in the differential diagnosis of pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma, Histopathology, vol.166, issue.6, pp.667-676, 2009. ,
DOI : 10.1111/j.1365-2559.2009.03298.x
Anti-mesothelial markers in sarcomatoid mesothelioma and other spindle cell neoplasms, Histopathology, vol.192, issue.3, pp.224-231, 2000. ,
DOI : 10.1046/j.1365-2559.1998.00349.x
Differential diagnosis of sarcomatoid mesothelioma from true sarcoma and sarcomatoid carcinoma using immunohistochemistry, Pathology International, vol.27, issue.2, pp.75-83, 2008. ,
DOI : 10.1111/j.1440-1827.2007.02193.x
Podoplanin is a Better Immunohistochemical Marker for Sarcomatoid Mesothelioma Than Calretinin, The American Journal of Surgical Pathology, vol.32, issue.1, pp.123-127, 2008. ,
DOI : 10.1097/PAS.0b013e31814faacf
Expression of CEA and trophoblastic cell markers by lung carcinoma in association with histological characteristics and serum marker levels, Eur. J. Cancer Prev, vol.7, issue.1, pp.51-60, 1998. ,
Pulmonary giant cell carcinoma: pathological entity or morphological phenotype? Histopathology 1998 mars, pp.225-231 ,
GYNECOMASTIA ATTRIBUTABLE TO HUMAN CHORIONIC GONADOTROPIN-SECRETING GIANT CELL CARCINOMA OF LUNG, Endocrine Practice, vol.9, issue.3, pp.233-235, 2003. ,
DOI : 10.4158/EP.9.3.233
Somatic mutations affect key pathways in lung adenocarcinoma, Nature, vol.32, issue.7216, pp.1069-1075, 2008. ,
DOI : 10.1038/nature07423
Lung Cancer, New England Journal of Medicine, vol.359, issue.13, pp.1367-1380, 2008. ,
DOI : 10.1056/NEJMra0802714
Sarcomatoid adenocarcinoma of the lung: clinicopathological, immunohistochemical and molecular analyses, Anticancer Res, vol.22, issue.6B, pp.3477-3483, 2002. ,
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non???Small-Cell Lung Cancer to Gefitinib, New England Journal of Medicine, vol.350, issue.21, pp.2129-2139, 2004. ,
DOI : 10.1056/NEJMoa040938
Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer, New England Journal of Medicine, vol.361, issue.10, pp.958-967, 2009. ,
DOI : 10.1056/NEJMoa0904554
Genetic Heterogeneity of EGFR Mutation in Pleomorphic Carcinoma of the Lung: Response to Gefitinib and Clinical Outcome, Japanese Journal of Clinical Oncology, vol.39, issue.4, pp.267-270, 2009. ,
DOI : 10.1093/jjco/hyn155
EGFR and KRAS status of primary sarcomatoid carcinomas of the lung: Implications for anti-EGFR treatment of a rare lung malignancy, International Journal of Cancer, vol.12, issue.10, pp.2479-2482, 2009. ,
DOI : 10.1002/ijc.24610
URL : https://hal.archives-ouvertes.fr/hal-00435717
EGFR and p53 Status of Pulmonary Pleomorphic Carcinoma: Implications for EGFR Tyrosine Kinase Inhibitors Therapy of an Aggressive Lung Malignancy, Annals of Surgical Oncology, vol.2, issue.10, 2011. ,
DOI : 10.1245/s10434-011-1621-7
Epidermal Growth Factor Receptor Gene Mutations and Increased Copy Numbers Predict Gefitinib Sensitivity in Patients With Recurrent Non???Small-Cell Lung Cancer, Journal of Clinical Oncology, vol.23, issue.28, pp.6829-6837, 2005. ,
DOI : 10.1200/JCO.2005.01.0793
Mutations within the tyrosine kinase domain of EGFR gene specifically occur in lung adenocarcinoma patients with a low exposure of tobacco smoking, British Journal of Cancer, vol.11, issue.6, pp.896-903, 2006. ,
DOI : 10.1016/j.lungcan.2005.08.006
Molecular Genetics of Lung Cancer, Annual Review of Medicine, vol.54, issue.1, pp.73-87, 2003. ,
DOI : 10.1146/annurev.med.54.101601.152202
Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFRtargeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer. The Lancet Oncology, pp.962-972, 2008. ,
BRAF and RAS mutations in human lung cancer and melanoma, Cancer Res, vol.62, issue.23, pp.6997-7000, 2002. ,
Mutations of the BRAF gene in human cancer, Nature, vol.7, issue.6892, pp.949-954, 2002. ,
DOI : 10.1006/geno.2000.6354
Missense mutations of the BRAF gene in human lung adenocarcinoma, Cancer Res, vol.62, issue.23, pp.7001-7003, 2002. ,
K-ras gene mutational analysis supports a monoclonal origin of biphasic pleomorphic carcinoma of the lung, Modern Pathology, vol.1378, issue.5, pp.538-546, 2004. ,
DOI : 10.1038/modpathol.3800058
-2 and p53 Analysis, American Journal of Clinical Pathology, vol.106, issue.4, pp.487-492, 1996. ,
DOI : 10.1093/ajcp/106.4.487
URL : https://hal.archives-ouvertes.fr/hal-00019473
Genome maintenance mechanisms for preventing cancer, Nature, vol.411, issue.6835, pp.366-374, 2001. ,
DOI : 10.1038/35077232
DNA sequence analysis of exons 2 through 11 and immunohistochemical staining are required to detect all known p53 alterations in human malignancies, Oncogene, vol.13, issue.9, pp.1971-1981, 1996. ,
EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset, Modern Pathology, vol.8, issue.4, pp.508-515, 2009. ,
DOI : 10.1158/0008-5472.CAN-06-4774
Comprehensive Histologic Analysis of ALK-Rearranged Lung Carcinomas, The American Journal of Surgical Pathology, vol.35, issue.8 ,
DOI : 10.1097/PAS.0b013e3182233e06
Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung Cancer, PLoS ONE, vol.114, issue.6, p.20351, 2011. ,
DOI : 10.1371/journal.pone.0020351.s010
Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer, Science Translational Medicine, vol.2, issue.62, pp.62-93, 2010. ,
DOI : 10.1126/scitranslmed.3001451
Silencing the MET oncogene leads to regression of experimental tumors and metastases, Oncogene, vol.212, issue.5, pp.684-693, 2008. ,
DOI : 10.1002/jcb.10358
MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib, Proceedings of the National Academy of Sciences, vol.104, issue.52, pp.20932-20937, 2007. ,
DOI : 10.1073/pnas.0710370104
Molecular profiles of EGFR, K-ras, c-met, and FGFR in pulmonary pleomorphic carcinoma, a rare lung malignancy, Journal of Cancer Research and Clinical Oncology, vol.39, issue.8, pp.1203-1211, 2011. ,
DOI : 10.1007/s00432-011-0986-0
The phosphatidylinositol 3-Kinase???AKT pathway in human cancer, Nature Reviews Cancer, vol.2, issue.7, pp.489-501, 2002. ,
DOI : 10.1038/nrc839
Reduced PTEN expression in breast cancer cells confers susceptibility to inhibitors of the PI3 kinase/Akt pathway, Annals of Oncology, vol.15, issue.10, pp.1510-1516, 2004. ,
DOI : 10.1093/annonc/mdh388
Temsirolimus in renal cell carcinoma with sarcomatoid differentiation: a report of three cases, Medical Oncology, vol.101, issue.7, 2011. ,
DOI : 10.1007/s12032-011-9976-y
An Overview of Epithelio-Mesenchymal Transformation, Cells Tissues Organs, vol.154, issue.1, pp.8-20, 1995. ,
DOI : 10.1159/000147748
Global regulatory logic for specification of an embryonic cell lineage, Proceedings of the National Academy of Sciences, vol.105, issue.16, pp.5955-5962, 2008. ,
DOI : 10.1073/pnas.0711220105
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis, Cell, vol.117, issue.7, pp.927-939, 2004. ,
DOI : 10.1016/j.cell.2004.06.006
Erk5 Controls Slug Expression and Keratinocyte Activation during Wound Healing, Molecular Biology of the Cell, vol.19, issue.11, pp.4738-4749, 2008. ,
DOI : 10.1091/mbc.E07-10-1078
URL : https://hal.archives-ouvertes.fr/inserm-00318681
Epithelial???mesenchymal transitions in tumour progression, Nature Reviews Cancer, vol.59, issue.6, pp.442-454, 2002. ,
DOI : 10.1038/nrc822
A role for cadherins in tissue formation, Development, vol.122, issue.10, pp.3185-3194, 1996. ,
Spatial and temporal dissection of immediate and early events following cadherin-mediated epithelial cell adhesion, The Journal of Cell Biology, vol.120, issue.5, pp.1217-1226, 1993. ,
DOI : 10.1083/jcb.120.5.1217
Loss of E-Cadherin Promotes Metastasis via Multiple Downstream Transcriptional Pathways, Cancer Research, vol.68, issue.10, pp.3645-3654, 2008. ,
DOI : 10.1158/0008-5472.CAN-07-2938
Hypermethylation of E-cadherin gene is frequent and independent of p16INK4A methylation in non-small cell lung cancer: Potential prognostic implication, Oncology Reports, vol.12, issue.2, pp.389-395, 2004. ,
DOI : 10.3892/or.12.2.389
IN NON-SMALL CELL LUNG CANCER, Experimental Lung Research, vol.6, issue.7, pp.541-553, 2009. ,
DOI : 10.1158/1078-0432.CCR-04-1962
URL : https://hal.archives-ouvertes.fr/inserm-00773345
Promoter-hypermethylation associated defective expression of E-cadherin in primary non-small cell lung cancer, Lung Cancer, vol.62, issue.2, pp.162-172, 2008. ,
DOI : 10.1016/j.lungcan.2008.03.023
Sustained induction of epithelial to mesenchymal transition activates DNA methylation of genes silenced in basal-like breast cancers, Proceedings of the National Academy of Sciences, vol.105, issue.39, pp.14867-14872, 2008. ,
DOI : 10.1073/pnas.0807146105
genes in nonsmall cell lung cancer and its relation to clinicopathologic features, Cancer, vol.17, issue.12, pp.2785-2792, 2007. ,
DOI : 10.1002/cncr.23113
The E-cadherin cell???cell adhesion complex and lung cancer invasion, metastasis, and prognosis, Lung Cancer, vol.36, issue.2, pp.115-124, 2002. ,
DOI : 10.1016/S0169-5002(01)00471-8
Altered E-cadherin and epidermal growth factor receptor expressions are associated with patient survival in lung cancer: a study utilizing high-density tissue microarray and immunohistochemistry, Modern Pathology, vol.17, issue.4, pp.430-439, 2004. ,
DOI : 10.1038/modpathol.3800041
Expression of E-Cadherin and Lymph Node Metastasis in Resected Non???Small-Cell Lung Cancer, Clinical Lung Cancer, vol.3, issue.2, pp.134-140, 2001. ,
DOI : 10.3816/CLC.2001.n.024
Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis, Cancer Res, vol.53, issue.7, pp.1696-1701, 1993. ,
Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?, Nature Reviews Cancer, vol.176, issue.6, pp.415-428, 2007. ,
DOI : 10.1038/nrc2131
The TWIST1 oncogene is a direct target of hypoxia-inducible factor-2??, Oncogene, vol.117, issue.11, pp.1501-1510, 2008. ,
DOI : 10.1038/sj.onc.1210795
VHL Promotes E2 Box-Dependent E-Cadherin Transcription by HIF-Mediated Regulation of SIP1 and Snail, Molecular and Cellular Biology, vol.27, issue.1, pp.157-169, 2007. ,
DOI : 10.1128/MCB.00892-06
Oxygen deprivation inhibits basal keratinocyte proliferation in a model of human skin and induces regio-specific changes in the distribution of epidermal adherens junction proteins, aquaporin-3, and glycogen, Wound Repair and Regeneration, vol.17, issue.4, pp.606-616, 2009. ,
DOI : 10.1111/j.1524-475X.2009.00515.x
Transcription Repressor Slug Promotes Carcinoma Invasion and Predicts Outcome of Patients with Lung Adenocarcinoma, Clinical Cancer Research, vol.11, issue.22, pp.8070-8078, 2005. ,
DOI : 10.1158/1078-0432.CCR-05-0687
The SLUG zinc-finger protein represses E-cadherin in breast cancer, Cancer Res, vol.62, issue.6, pp.1613-1618, 2002. ,
Cancer development induced by graded expression of Snail in mice, Human Molecular Genetics, vol.14, issue.22, pp.3449-3461, 2005. ,
DOI : 10.1093/hmg/ddi373
Prognostic value of tumor ???budding??? in patients with colorectal cancer, Diseases of the Colon & Rectum, vol.36, issue.7, pp.627-635, 1993. ,
DOI : 10.1007/BF02238588
Tumor Budding as an Indicator of Isolated Tumor Cells in Lymph Nodes From Patients With Node-Negative Colorectal Cancer, Diseases of the Colon & Rectum, vol.48, issue.2, pp.292-302, 2005. ,
DOI : 10.1007/s10350-004-0773-y
Loss of membranous Ep-CAM in budding colorectal carcinoma cells, Modern Pathology, vol.76, issue.2, pp.221-232, 2007. ,
DOI : 10.1038/modpathol.3800733
Epithelial- Mesenchymal Transition (EMT) Protein Expression in a Cohort of Stage II Colorectal Cancer Patients With Characterized Tumor Budding and Mismatch Repair Protein Status [Internet], Int J Surg Pathol, 2011. ,
Histopathologic Features of the Tumor Budding in Adenocarcinoma of the Lung: Tumor Budding As an Index to Predict the Potential Aggressiveness, Journal of Thoracic Oncology, vol.5, issue.9, pp.1361-1368, 2010. ,
DOI : 10.1097/JTO.0b013e3181eaf2f3
Integrative Genomic and Proteomic Analyses Identify Targets for Lkb1-Deficient Metastatic Lung Tumors, Cancer Cell, vol.17, issue.6, pp.547-559, 2010. ,
DOI : 10.1016/j.ccr.2010.04.026
Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung, Cancer Res, vol.62, issue.13, pp.3659-3662, 2002. ,
Distinctive gene expression of human lung adenocarcinomas carrying LKB1 mutations, Oncogene, vol.23, issue.29, pp.5084-5091, 2004. ,
DOI : 10.1038/sj.onc.1207665
Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade, Journal of Biology, vol.2, issue.4, p.28, 2003. ,
DOI : 10.1186/1475-4924-2-28
Peutz?Jeghers LKB1 mutants fail to activate GSK-3?, preventing it from inhibiting Wnt signaling, Molecular Genetics and Genomics, vol.73, issue.2, pp.184-196, 2005. ,
DOI : 10.1007/s00438-005-1124-y
The Peutz-Jegher Gene Product LKB1 Is a Mediator of p53-Dependent Cell Death, Molecular Cell, vol.7, issue.6, pp.1307-1319, 2001. ,
DOI : 10.1016/S1097-2765(01)00258-1
LKB1 Associates with Brg1 and Is Necessary for Brg1-induced Growth Arrest, Journal of Biological Chemistry, vol.276, issue.35, pp.32415-32418, 2001. ,
DOI : 10.1074/jbc.C100207200
LKB1 (XEEK1) regulates Wnt signalling in vertebrate development, Nature Cell Biology, vol.5, issue.10, pp.889-894, 2003. ,
DOI : 10.1038/ncb1048
Growth arrest by the LKB1 tumor suppressor: induction of p21WAF1/CIP1, Human Molecular Genetics, vol.11, issue.13, pp.1497-1504, 2002. ,
DOI : 10.1093/hmg/11.13.1497
Complete Polarization of Single Intestinal Epithelial Cells upon Activation of LKB1 by STRAD, Cell, vol.116, issue.3, pp.457-466, 2004. ,
DOI : 10.1016/S0092-8674(04)00114-X
Fibronectin Stimulates Non-Small Cell Lung Carcinoma Cell Growth through Activation of Akt/Mammalian Target of Rapamycin/S6 Kinase and Inactivation of LKB1/AMP-Activated Protein Kinase Signal Pathways, Cancer Research, vol.66, issue.1, pp.315-323, 2006. ,
DOI : 10.1158/0008-5472.CAN-05-2367
Growth and molecular profile of lung cancer cells expressing ectopic LKB1: down-regulation of the phosphatidylinositol 3'- phosphate kinase/PTEN pathway, Cancer Res, vol.63, issue.6, pp.1382-1388, 2003. ,
Role of LKB1 in lung cancer development, British Journal of Cancer, vol.159, issue.5, pp.683-688, 2008. ,
DOI : 10.1128/MCB.22.10.3425-3436.2002
Involvement of LKB1 in epithelial???mesenchymal transition (EMT) of human lung cancer cells, Lung Cancer, vol.70, issue.2, pp.136-145, 2010. ,
DOI : 10.1016/j.lungcan.2010.02.004
The role of LKB1 in lung cancer [Internet]. Fam Cancer, 2011. ,
The Fallacy of Epithelial Mesenchymal Transition in Neoplasia, Cancer Research, vol.65, issue.14, pp.5996-6000, 2005. ,
DOI : 10.1158/0008-5472.CAN-05-0699
Notch and Epithelial-Mesenchyme Transition in Development and Tumor Progression: Another Turn of the Screw, Cell Cycle, vol.3, issue.6, pp.718-721, 2004. ,
DOI : 10.4161/cc.3.6.949
Exposure to occupational carcinogens and lung cancer risk. Evolution of epidemiological estimates of attributable fraction, Acta Biomed, vol.79, issue.1, pp.34-42, 2008. ,
Asbestos-induced lung diseases: an update, Translational Research, vol.153, issue.4, pp.143-152, 2009. ,
DOI : 10.1016/j.trsl.2009.01.004
Cancer bronchique et facteurs de risque: existe-t-il desmarqueurs phénotypiques specifiques?, 2009. ,
Markers of Epithelial-Mesenchymal Transition and Epithelial Differentiation in Sarcomatoid Carcinoma: Utility in the Differential Diagnosis With Sarcoma, Applied Immunohistochemistry & Molecular Morphology, vol.16, issue.3, pp.251-62, 2008. ,
DOI : 10.1097/PAI.0b013e318156e9b4